Bilimsel çalışmalar

Prof. Dr. Lütfiye Demir

165 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. E. Ulusal bilimsel toplantılarda sunulan ve bildiri kitaplarında basılan bildiriler:

    Kaynak: medicana.com.tr profil sayfası

  2. B. Uluslararası bilimsel toplantılarda sunulan ve bildiri kitabında (Proceedings) basılan bildiriler:

    Kaynak: medicana.com.tr profil sayfası

  3. A1. Demir L, Somali I, Oktay Tarhan M, Erten C, Ellidokuz H, Can A, Dirican A, Vedat Bayoglu I. The toxicity and efficacy of Nordic-FLOX regimen as adjuvant treatment of stage III colon cancer. J BUON 2011;16(4):682-8.

    Kaynak: medicana.com.tr profil sayfası

  4. A2. Demir L, Erten C, Yigit SC, Can A, Dirican A, Bayoglu V, Kucukzeybek Y, Somali I, Tarhan MO. Intramammary lymph node metastasis in a patient with ovarian carcinoma and a brief review of the literature. Contemp Oncol (Pozn). 2012;16(2):108-10.

    Kaynak: medicana.com.tr profil sayfası

  5. A3. Yigit S, Demir L, Tarhan MO, Cabuk FK, Ellidokuz H, Erten C, Somali I, Dirican A, Cakalagaoglu F. The clinicopathological significance of Bax and Bcl-2 protein expression with tumor infiltrating lymphocytes in ovarian carcinoma. Neoplasma2012;59(5):475-85.

    Kaynak: medicana.com.tr profil sayfası

  6. A4. Demir L, Can A, Dirican A, Bayoğlu V, Rezanko TA, Akyol M, Kucukzeybek Y, Erten C, Tarhan MO. Malignant fibrous histiocytoma of the spermatic cord in a patient with polycystic kidney disease; review of the literature. Clin Genitourin Cancer. 2012;10(4):280-3.

    Kaynak: medicana.com.tr profil sayfası

  7. A5. Kaplan MA, Isikdogan A, Koca D, Kucukoner M, Gumusay O, Yildiz R, Dayan A, Demir L, Geredeli C, Kocer M, Arslan UY, Inal A, Unal OU, Mert AG, Bilici M, Ozkan M, Elkiran ET, Yaman S, Durnalı AG, Suner A, Alici S, Tarhan MO, Boruban C, Urakci Z, Buyukberber S. Biological subtypes and survival outcomes in breast cancer patients with brain metastases (study of the Anatolian Society of Medical Oncology). Oncology. 2012;83(3):141-50.

    Kaynak: medicana.com.tr profil sayfası

  8. A6. Demir L, Erten C, Somali I, Can A, Dirican A, Bayoglu V, Kucukzeybek Y, Altinboga AA, Ermete M, Oztop RM, Tarhan MO. Metastases of renal cell carcinoma to the larynx and thyroid: Two case reports on metastasis developing years after nephrectomy. Can Urol Assoc J. 2012;6(5):E209-12.

    Kaynak: medicana.com.tr profil sayfası

  9. A7. Kucukzeybek Y, Dirican A, Erten C, Somali I, Can A, Demir L, Bayoglu IV, Akyol M, Medeni M, Tarhan MO. Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer. Asian Pac J Cancer Prev. 2012;13(6):2771-4.

    Kaynak: medicana.com.tr profil sayfası

  10. A8. Kamali S, Artim-Esen B, Erer B, Ozdener L, Gul A, Ocal L, Aral O, Inanc M. Re-evaluation of 129 patients with systemic necrotizing vasculitides by using classification algorithm according to consensus methodology. Clin Rheumatol. 2012;31(2):325-8.

    Kaynak: medicana.com.tr profil sayfası

  11. A9. Kaplan MA, Isikdogan A, Koca D, Kucukoner M, Gumusay O, Yildiz R, Dayan A, Demir L, Geredeli C, Kocer M, Arslan UY, Inal A, Akman T, Coskun U, Sener N, Inanc M, Elkiran ET, Ozdemir NY, Durnalı AG, Suner A, Alici S, Tarhan MO, Boruban C, Oksuzoglu B, Urakci Z. Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology. Breast Cancer. 2013 DOI: 10.1007/s12282-013-0441-y.

    Kaynak: medicana.com.tr profil sayfası

  12. A10. Demir L, Can A, Oztop R, Dirican A, Bayoglu V, Akyol M, Kucukzeybek Y, Erten C, Somali I, Tarhan MO. Malignant epithelioid hemangioendothelioma progressing after chemotherapy and Interferon treatment: a case presentation and a brief review of the literature. J Cancer Res Ther. 2013;9(1):125-7.

    Kaynak: medicana.com.tr profil sayfası

  13. A11. Tarhan MO, Demir L, Somali I, Yigit S, Erten C, Alacacioglu A, Ellidokuz H, Seseogullari O, Kucukzeybek Y, Can A, Dirican A, Bayoglu V, Akyol M. The clinicopathological evaluation of the breast cancer patients with brain metastases: predictors of survival. Clin Exp Metastasis. 2013;30(2):201-13.

    Kaynak: medicana.com.tr profil sayfası

  14. A12. Dirican A, Küçükzeybek Y, Somalι I, Erten C, Demir L, Can A, Bayoğlu IV, Ermete M, Altιnboğa AA, Tarhan MO. Cutaneous and subcutaneous metastases from bladder carcinoma. Contemp Oncol (Pozn). 2012;16(5):451-2.

    Kaynak: medicana.com.tr profil sayfası

  15. A13. Tarhan MO, Gonel A, Kucukzeybek Y, Erten C, Cuhadar S, Yigit SC, Atay A, Somali I, Dirican A, Demir L, Koseoglu M. Prognostic significance of circulating tumor cells and serum CA15-3 levels in metastatic breast cancer, single center experience, preliminary results. Asian Pac J Cancer Prev. 2013;14(3):1725-9.

    Kaynak: medicana.com.tr profil sayfası

  16. A14. Dirican A, Ekinci N, Avci A, Akyol M, Alacacioglu A, Kucukzeybek Y, Somali I, Erten C, Demir L, Can A, Bayoglu IV, Koyuncu B, Tarhan MO. Prognostic and Predictive Value of Hematologic Parameters in Patients with Metastatic Renal Cell Cancer: Second Line Sunitinib Treatment Following IFN-alpha; Preliminary Study. Asian Pacific Journal of Cancer Prevention 2013;14(3):2101-5.

    Kaynak: medicana.com.tr profil sayfası

  17. A15. Dirican A, Ekinci N, Avci A, Akyol M, Alacacioglu A, Kucukzeybek Y, Somali I, Erten C, Demir L, Can A, Bayoglu IV, Koyuncu B, Tarhan MO. The Effects of Hematological Parameters and Tumor-Infiltrating Lymphocytes on Prognosis in Patients with Gastric Cancer. Cancer Biomarkers 2013 1;13(1):11-20.

    Kaynak: medicana.com.tr profil sayfası

  18. A16. Dirican A, Kucukzeybek Z, Tarhan MO, Somali I, Erten C, Demir L, Can A, Bayoglu V, Akyol M, Ekinci N, Medeni M, Alacacioglu A. One-Day DCF Regimen in Patients with Metastatic Gastric Cancer. Tumori 2013;99:145-148.

    Kaynak: medicana.com.tr profil sayfası

  19. A17. Demir L, Yigit S, Ellidokuz H, Erten C, Somali I, Kucukzeybek Y, Alacacioglu A, Cokmert S, Can A, Akyol M, Dirican A, Bayoglu V, Sari AA, Tarhan MO. Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs. Clinical Experimantal Metastasis 2013;30(8):1047-1062.

    Kaynak: medicana.com.tr profil sayfası

  20. A18. Erten C, Demir L, Somali I, Alacacioglu A, Kucukzeybek Y, Akyol M, Can A, Dirican A, Bayoglu V, Tarhan MO. Cisplatin plus gemcitabine for treatment of breast cancer patients with brain metastases; is it a preferential option for triple negative patients?. Asian Pacific Journal of Cancer Prevention 2013;14(6):3711-3717.

    Kaynak: medicana.com.tr profil sayfası

  21. A19. Demir L, Ekinci N, Erten C, Kucukzeybek Y, Alacacioglu A, Somali I, Can A, Dirican A, Bayoglu V, Akyol M, Cakalagaoglu F, Tarhan MO. Does Immunohistochemistry Provide Additional Prognostic Data in Gastrointestinal Stromal Tumors? Asian Pacific Journal of Cancer Prevention 2013;14(8):4751-4758.

    Kaynak: medicana.com.tr profil sayfası

  22. A20. Somali I, Ustaoglu BY, Tarhan MO, Yigit SC, Demir L, Ellidokuz H, Erten C, Alacacioglu A. Clinicopathologic and Demographic Evaluation of Triple-Negative Breast Cancer Patients among a Turkish Patient Population: a Single Center Experience. Asian Pacific Journal of Cancer Prevention 2013;14(10):6013-6017.

    Kaynak: medicana.com.tr profil sayfası

  23. A21. Can A, Alacacioglu A, Kucukzeybek Y, Erten C, Cokmert S, Demir L, Dirican A, Bayoglu V, Akyol M, Aslan F, Tarhan MO. The relationship of insulin resistance and metabolic syndrome with known breast prognostic factors in postmenapausal breast cancer patients. J. BUON 2013;18(4):845-850.

    Kaynak: medicana.com.tr profil sayfası

  24. A22. Cokmert S, Demir L, Akder Sari A, Kucukzeybek Y, Can A, Akyol M, Bayoglu IV, Dirican A, Erten C, Tarhan MO. Synchronous appearance of a high-grade neuroendocrine carcinoma of the ampulla vater and sigmoid colon adenocarcinoma. Case Rep Oncol Med. 2013;2013:930359. doi: 10.1155/2013/930359.

    Kaynak: medicana.com.tr profil sayfası

  25. A23. Kuşku Cabuk F, Yığıt S, Demır L, Cakalağaoğlu F, Tarhan O. Correlation of survivin and MMP9 expressions with prognosis and clinicopathological parameters in surface epithelial ovarian carcinomas. Turk Patoloji Derg. 2014;30(1):30-7.

    Kaynak: medicana.com.tr profil sayfası

  26. A24. Cokmert S, Demir L, Akyol M, Bayoglu IV, Can A, Unek IT, Bolat FA. Clitoris metastasis from a retroperitoneal leiomyosarcoma: A case report. World J Clin Oncol. 2014;5(1):28-32.

    Kaynak: medicana.com.tr profil sayfası

  27. A25. Dirican A, Levent F, Alacacioglu A, Kucukzeybek Y, Varol U, Kocabas U, Senöz O, Emren SX, Demir L, Coban E, Aksun S, Sutcu R, Tarhan MO. Acute Cardiotoxic Effects of Adjuvant Trastuzumab Treatment and Its Relation to Oxidative Stress. Angiology, 2014. doi: 10.1177/0003319714523112.

    Kaynak: medicana.com.tr profil sayfası

  28. A26. Dirican A, Kucukzeybek Y, Alacacioglu A, Varol U, Aksun S, Bayoglu IV, Demir L, Coban E, Sutcu R, Tarhan MO. Impact of pre-angiogenic factors on the treatment effect of bevacizumab in patients with metastatic colorectal cancer. Med Oncol. 2014;31(4):905.

    Kaynak: medicana.com.tr profil sayfası

  29. A27. Cokmert S, Demir L, Can A, Akyol M, Vedat Bayoglu I, Dirican A, Kucukzeybek Y, Erten C, Oktay Tarhan M. Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer. J BUON. 2014 Jan-Mar;19(1):75-82.

    Kaynak: medicana.com.tr profil sayfası

  30. A28. Dirican A, Kucukzeybek Z, Somali I, Erten C, Demir L, Can A, Payzin B, Bayoglu V, Akyol M, Koseoglu M, Alacacioglu A, Tarhan MO, The association of hematologic parameters on prognosis of patients with metastatic renal cell carcinoma. J BUON 2013;18(2):413-419.

    Kaynak: medicana.com.tr profil sayfası

  31. A29. Dirican A, Kucukzeybek Y, Somali I, Erten C, Demir L, Can A, Bayoglu IV, Yigit SC, Unay FC, Yetimalar MH, Tarhan MO. Micro-metastases into the uterine leiomyoma from invasive ductal breast cancer under adjuvant tamoxifen therapy: case report. Eur J Gynaecol Oncol. 2012;33(6):652-5.

    Kaynak: medicana.com.tr profil sayfası

  32. A30. Akyol M, Demir L, Dirican A, Ekinci N, Can A, Bayoglu V, Alacacioglu A, Kucukzeybek Y, Cokmert S, Erten C, Cakalagaoglu F, Tarhan MO. Skin and maxillary sinus involvement of colon cancer. Contemp Oncol (Pozn). 2014;18(1):70-2

    Kaynak: medicana.com.tr profil sayfası

  33. A31. Demir L, Yigit S, Sadullahoglu C, Akyol M, Cokmert S, Kucukzeybek Y, Alacacioglu A, Cakalagaoglu F, Tarhan MO. Hormone Receptor, HER2/NEU and EGFR Expression in Ovarian Carcinoma - is here a Prognostic Phenotype? Asian Pac J Cancer Prev. 2014;15:9739-45.

    Kaynak: medicana.com.tr profil sayfası

  34. A32. Alacacioglu A, Ulger E, Varol U, Yildiz I, Salman T, Bayoglu V, Dirican A, Demir L, Akyol M, Yildiz Y, Kucukzeybek Y, Ataman G, Can H, Alacacioglu I, Tarhan MO. Depression, anxiety and sexual satisfaction in breast cancer patients and their partners-Izmir oncology group study. Asian Pac J Cancer Prev 2014;15:10631-6.

    Kaynak: medicana.com.tr profil sayfası

  35. A33. Alacacioglu A, Ulger E, Varol U, Yavuzsen T, Akyol M, Yildiz Y, Yildiz I, Bayoglu V, Dirican A, Demir L, Salman T, Kucukzeybek Y, Alacacioglu I, Can H, Tarhan MO. Sexual satisfaction, anxiety, depression and quality of life in testicular cancer survivors. Med Oncol. 2014;31(7):43.

    Kaynak: medicana.com.tr profil sayfası

  36. A34. Bayoglu IV, Kucukzeybek BB, Kucukzeybek Y, Varol U, Yildiz I, Alacacioglu A, Akyol M, Demir L, Dirican A, Yildiz Y, Salman T, Tarhan MO. Prognostic value of mesothelin expression in patients with triple negative and HER2-positive breast cancers. Biomed Pharmacother. 2015;70:190-5.

    Kaynak: medicana.com.tr profil sayfası

  37. A35. Vedat Bayoglu I, Yildiz I, Varol U, Cokmert S, Kucukzeybek Y, Alacacioglu A, Demir L, Dirican A, Akyol M, Yildiz Y, Oktay Tarhan M.Comparison of first-line bevacizumab in combination with mFOLFOX6 or XELOX in metastatic colorectal cancer.

    Kaynak: medicana.com.tr profil sayfası

  38. A36. Cokmert S, Ellidokuz H, Demir L, Fuzun M, Astarcioglu I, Aslan D, Yilmaz U, Oztop I. Survival outcomes of liver metastasectomy in colorectal cancer cases: a single-center analysis in Turkey.Asian Pac J Cancer Prev. 2014;15(13):5195-200.

    Kaynak: medicana.com.tr profil sayfası

  39. A37. Kucukzeybek Y, Dirican A, Demir L, Yildirim S, Akyol M, Yildiz Y, Bayoglu IV, Alacacioglu A, Varol U, Salman T, Yildiz I, Can H, Tarhan MO.Adjuvant Chemotherapy and Prognostic Factors in Stage II Colon Cancer - Izmir Oncology Group Study. Asian Pac J Cancer Prev. 2015;16(6):2413-8.

    Kaynak: medicana.com.tr profil sayfası

  40. A38. Akyol M, Ulger E, Alacacioglu A, Kucukzeybek Y, Bayoglu V, Yildiz Y, Yildiz I, Salman T, Varol U,Demir L, Dirican A, Gumus Z, Oktay Tarhan M.Quality of life in colorectal cancer patients: an Izmir Oncology Group (IZOG) study. J BUON 2015;20(4):1015-22.

    Kaynak: medicana.com.tr profil sayfası

  41. A39. Demir L, Akyol M, Bener S, Payzin KB, Erten C, Somali I, Can A, Dirican A, Bayoglu V, Kucukzeybek Y, Alacacioglu A, Calli AO, Tarhan MO. Prognostic evaluation of breast cancer patients with evident bone marrow metastasis. Breast J. 2014;20(3):279-87.

    Kaynak: medicana.com.tr profil sayfası

  42. A40. Bayoglu IV, Varol U, Yildiz I, Muslu U, Alacacioglu A, Kucukzeybek Y, Akyol M, Demir L, Dirican A, Cokmert S, Yildiz Y, Karabulut B, Uslu R, Tarhan MO.Second-line capecitabine and oxaliplatin combination for gemcitabine-resistant advanced pancreatic cancer. Asian Pac J Cancer Prev. 2014;15(17):7119-23.

    Kaynak: medicana.com.tr profil sayfası

  43. A41. Oktay E, Oflazoglu U, Varol Y, Tanriverdi O, Mermur N, Arda HU, Demir L, Keskin O, Ahmadli T, Somali I, Oztop I, Meydan N. The prognostic role of thyroid transcription factor-1 in lung adenocarcinoma. J Cancer Res Ther. 2018;14(Supplement):S1201-S1208.

    Kaynak: medicana.com.tr profil sayfası

  44. A42. Dural M, Demir L, Babayiğit E, Junushova B, Mert KU, Ulus T, Çavuşoğlu Y, Yıldız B, Dinçer M, Görenek B. Fragmented QRS formation and its predictors in patients with breast cancer receiving anthracycline-based chemotherapy. J Electrocardiol. 2019;54:5-9.

    Kaynak: medicana.com.tr profil sayfası

  45. A43. Cokmert S, Tanriverdi O, Karapolat I, Demir L, Bayoglu V, Can A, Akyol M, Yilmaz Y, Oktay Tarhan M. The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study. J BUON. 2016;21(6):1410-1418.

    Kaynak: medicana.com.tr profil sayfası

  46. A44. Bayoglu İV, Yildiz I, Varol U, Cokmert S, Alacacıoğlu A, Kucukzeybek Y, Akyol M, Demir L, Dirican A, Tarhan O. Uracil/tegafur as a possible salvage therapy in chemo-refractory colorectal cancer patients: a single institutional retrospective study. Contemp Oncol (Pozn). 2015;19(5):385-90.

    Kaynak: medicana.com.tr profil sayfası

  47. A45. Dirican A, Varol U, Kucukzeybek Y, Alacacioglu A, Erten C, Somali I, Can A, Demir L, Bayoglu IV, Akyol M, Yildiz Y, Koyuncu B, Coban E, Tarhan MO. Treatment of metastatic colorectal cancer with or without bevacizumab: can the neutrophil/lymphocyte ratio predict the efficiency of bevacizumab? Asian Pac J Cancer Prev. 2014;15(12):4781-6.

    Kaynak: medicana.com.tr profil sayfası

  48. A46. Akyol M, Demir L, Alacacioglu A, Ellidokuz H, Kucukzeybek Y, Yildiz Y, Gumus Z, Bayoglu V, Yildiz I, Salman T, Varol U, Kucukzeybek B, Demir L, Dirican A, Sutcu R, Tarhan MO. The Effects of Adjuvant Endocrine Treatment on Serum Leptin, Serum Adiponectin and Body Composition in Patients with Breast Cancer: The Izmir Oncology Group (IZOG) Study. Chemotherapy 2015;61(2):57-64.

    Kaynak: medicana.com.tr profil sayfası

  49. A47. Demir L, Ekinci N, Erten C, Somali I, Can A, Dirican A, Cokmert S, Bayoglu V, Akyol M, Kucukzeybek Y, Alacacioglu A, Tarhan MO. The impact of cell proliferation markers and p53 mutation status on prognosis of non-metastatic colon cancer. J Surg Oncol. 2014;109(7):665-75.

    Kaynak: medicana.com.tr profil sayfası

  50. A48. Dirican A, Kucukzeybek BB, Alacacioglu A, Kucukzeybek Y, Erten C, Varol U, Somali I, Demir L, Bayoglu IV, Yildiz Y, Akyol M, Koyuncu B, Coban E, Ulger E, Unay FC, Tarhan MO. Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer? Int J Clin Oncol. 2014.

    Kaynak: medicana.com.tr profil sayfası